Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteasome Endopeptidase Complex | 4 | 2010 | 1319 | 0.630 |
Why?
|
| Amyloid beta-Protein Precursor | 4 | 2010 | 1117 | 0.570 |
Why?
|
| Ubiquitin | 3 | 2010 | 843 | 0.510 |
Why?
|
| Huntington Disease | 3 | 2008 | 1147 | 0.500 |
Why?
|
| Down Syndrome | 3 | 2010 | 919 | 0.360 |
Why?
|
| Electron Transport Complex III | 1 | 2008 | 31 | 0.310 |
Why?
|
| Electron Transport Complex II | 1 | 2008 | 53 | 0.310 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2014 | 605 | 0.300 |
Why?
|
| Nerve Growth Factor | 2 | 2010 | 156 | 0.260 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2005 | 156 | 0.240 |
Why?
|
| Frontal Lobe | 1 | 2010 | 1426 | 0.220 |
Why?
|
| Acetylcholine | 2 | 2002 | 629 | 0.210 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2022 | 1887 | 0.200 |
Why?
|
| Cholinergic Fibers | 1 | 2002 | 69 | 0.200 |
Why?
|
| Neurons | 5 | 2014 | 9514 | 0.190 |
Why?
|
| Muscle Proteins | 1 | 2007 | 1165 | 0.190 |
Why?
|
| Receptors, Muscarinic | 1 | 2002 | 157 | 0.190 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 664 | 0.180 |
Why?
|
| Alzheimer Disease | 5 | 2021 | 8759 | 0.170 |
Why?
|
| Norepinephrine | 1 | 2002 | 898 | 0.160 |
Why?
|
| Parkinson Disease | 4 | 2020 | 2893 | 0.150 |
Why?
|
| Receptor, Muscarinic M1 | 2 | 2010 | 25 | 0.140 |
Why?
|
| Synaptic Transmission | 1 | 2002 | 1177 | 0.130 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2014 | 9 | 0.120 |
Why?
|
| Viper Venoms | 1 | 2014 | 16 | 0.120 |
Why?
|
| Pluripotent Stem Cells | 1 | 2022 | 809 | 0.120 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 58 | 0.120 |
Why?
|
| Succinimides | 2 | 2005 | 83 | 0.110 |
Why?
|
| Hippocampus | 3 | 2005 | 3785 | 0.110 |
Why?
|
| Muscarinic Agonists | 2 | 2005 | 91 | 0.110 |
Why?
|
| Homeodomain Proteins | 1 | 2002 | 2429 | 0.100 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 1095 | 0.100 |
Why?
|
| Mesencephalon | 2 | 2022 | 338 | 0.090 |
Why?
|
| Mice, Transgenic | 3 | 2010 | 9561 | 0.090 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 2010 | 113 | 0.090 |
Why?
|
| Skin | 1 | 2004 | 4503 | 0.090 |
Why?
|
| Brain | 5 | 2021 | 27360 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2010 | 4146 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 3 | 2008 | 4413 | 0.080 |
Why?
|
| Behavior, Animal | 2 | 2008 | 1862 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2014 | 3803 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2014 | 2885 | 0.070 |
Why?
|
| Cognition | 1 | 2005 | 7073 | 0.070 |
Why?
|
| Quinolinic Acid | 1 | 2007 | 67 | 0.070 |
Why?
|
| Nitro Compounds | 1 | 2007 | 74 | 0.070 |
Why?
|
| Leupeptins | 1 | 2007 | 113 | 0.070 |
Why?
|
| Transcriptional Activation | 2 | 2003 | 1750 | 0.070 |
Why?
|
| Propionates | 1 | 2007 | 180 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 11928 | 0.070 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2010 | 616 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2014 | 2493 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 1942 | 0.060 |
Why?
|
| Dopamine beta-Hydroxylase | 2 | 2003 | 74 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2003 | 12168 | 0.060 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2005 | 34 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2002 | 5812 | 0.060 |
Why?
|
| MPTP Poisoning | 1 | 2005 | 37 | 0.060 |
Why?
|
| Escape Reaction | 1 | 2005 | 57 | 0.060 |
Why?
|
| Herbicides | 1 | 2005 | 104 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2007 | 899 | 0.060 |
Why?
|
| Animals | 11 | 2022 | 169246 | 0.050 |
Why?
|
| Maze Learning | 1 | 2005 | 482 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2008 | 5804 | 0.050 |
Why?
|
| Parasympathomimetics | 1 | 2002 | 28 | 0.050 |
Why?
|
| Mice | 6 | 2020 | 82029 | 0.050 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2014 | 2043 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2003 | 1683 | 0.050 |
Why?
|
| Cell Survival | 2 | 2014 | 5777 | 0.050 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2003 | 367 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 542 | 0.050 |
Why?
|
| Atropine | 1 | 2002 | 244 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 18349 | 0.050 |
Why?
|
| Muscarinic Antagonists | 1 | 2002 | 136 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2003 | 5797 | 0.050 |
Why?
|
| Cell Count | 1 | 2005 | 1832 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2014 | 2937 | 0.050 |
Why?
|
| Corpus Striatum | 1 | 2007 | 1224 | 0.040 |
Why?
|
| 5' Untranslated Regions | 1 | 2002 | 255 | 0.040 |
Why?
|
| Dimerization | 1 | 2002 | 887 | 0.040 |
Why?
|
| Models, Neurological | 1 | 2008 | 1776 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2014 | 19015 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 2003 | 3055 | 0.040 |
Why?
|
| Growth Substances | 1 | 2002 | 759 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2005 | 2678 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 2022 | 11669 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 462 | 0.040 |
Why?
|
| Putamen | 1 | 2020 | 291 | 0.040 |
Why?
|
| Mitochondria | 1 | 2012 | 3681 | 0.040 |
Why?
|
| Reaction Time | 1 | 2005 | 2101 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 6514 | 0.040 |
Why?
|
| Dopamine | 2 | 2022 | 1592 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 3740 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2002 | 792 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 1890 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3814 | 0.040 |
Why?
|
| Rats | 3 | 2022 | 23760 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2005 | 5027 | 0.040 |
Why?
|
| Transfection | 2 | 2003 | 5755 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2002 | 1419 | 0.040 |
Why?
|
| Basal Ganglia | 1 | 2020 | 553 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2005 | 6229 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2007 | 4176 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2020 | 2120 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2020 | 2627 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2004 | 6340 | 0.030 |
Why?
|
| Arsenicals | 1 | 2014 | 117 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2007 | 5151 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2005 | 3610 | 0.030 |
Why?
|
| Oxidopamine | 1 | 2014 | 169 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 195 | 0.030 |
Why?
|
| Binding Sites | 1 | 2002 | 6020 | 0.030 |
Why?
|
| Humans | 13 | 2022 | 768166 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 414 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 615 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 11095 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2020 | 4833 | 0.020 |
Why?
|
| Ubiquinone | 1 | 2012 | 181 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 23645 | 0.020 |
Why?
|
| Zebrafish | 1 | 2002 | 3035 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2021 | 2907 | 0.020 |
Why?
|
| Protein Binding | 1 | 2002 | 9343 | 0.020 |
Why?
|
| Gene Expression | 1 | 2002 | 7598 | 0.020 |
Why?
|
| Phenols | 1 | 2012 | 526 | 0.020 |
Why?
|
| Age Factors | 1 | 2005 | 18412 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 3611 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 9615 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 6231 | 0.020 |
Why?
|
| Aging | 2 | 2021 | 8744 | 0.020 |
Why?
|
| Sirolimus | 1 | 2012 | 1540 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2005 | 317 | 0.020 |
Why?
|
| Indoles | 1 | 2012 | 1836 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 6669 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 8128 | 0.010 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2003 | 41 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 2003 | 97 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 22379 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 294 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 10760 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2003 | 1142 | 0.010 |
Why?
|
| Response Elements | 1 | 2003 | 307 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2014 | 3914 | 0.010 |
Why?
|
| Receptors, Cholinergic | 1 | 2002 | 244 | 0.010 |
Why?
|
| Long-Term Potentiation | 1 | 2002 | 290 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 30238 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 5341 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2003 | 1497 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 9523 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39348 | 0.010 |
Why?
|
| Female | 3 | 2014 | 397192 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2003 | 3074 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20760 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3800 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2003 | 1266 | 0.010 |
Why?
|
| Synapses | 1 | 2002 | 1765 | 0.010 |
Why?
|
| Cell Line | 1 | 2003 | 15597 | 0.000 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 9538 | 0.000 |
Why?
|
| Aged | 1 | 2020 | 171504 | 0.000 |
Why?
|
| Male | 1 | 2020 | 364719 | 0.000 |
Why?
|
Concepts
(158)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_